LifeVantage Corporation LFVN R2K

Consumer Defensive · Packaged Foods · United States

https://www.lifevantage.com

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Market & Price

Market Cap

$99.29M

Current Price

$7.87

High / Low (52W)

$14.22 / $4.02

Beta

0.55

Valuation

Stock P/E

17.49

Industry PE

18.88

Forward P/E

17.23

PEG Ratio

0.36

Book Value

$2.58

Price to Book

3.05

P/S

0.51

EV/EBITDA

9.69

Dividend Yield

2.54%

Profitability & Returns

ROCE

27.27%

ROE

17.08%

ROA

6.44%

Profit Margin

2.94%

Op Margin

4.07%

EPS (Latest Qtr)

$0.11

EPS (TTM)

$0.45

Balance Sheet & Liquidity

Debt/Equity

0.31

Quick Ratio

0.85

Current Ratio

1.96

Debt

$10.21M

Total Assets

$71.96M

Current Assets

$50.89M

Working Capital

$23.68M

Ownership

Promoter Holding

16.43%

Chg in Prom Hold

FII / Inst Holding

67.28%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$97.01M

Total Revenue (TTM)

$195.32M

EBITDA

$10.01M

Free Cash Flow

$2.03M

Operating Cash Flow

$6.51M

Shares Outstanding

12.62M

Gross Margin

78.14%

Payout Ratio

40.00%

Growth (CAGR)

Revenue 5Y

3.46%

Profit 5Y

46.48%

Revenue (YoY)

-25.20%

Earnings (YoY)

-58.50%

PROS

Healthy ROCE of 27.3%.
Profit CAGR of 46.5% over 5 years.
Attractive dividend yield of 2.54%.
Generates positive free cash flow.

CONS

Trading 44.7% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).
RSI at 75 suggests overbought conditions.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	LFVN LifeVantage Corporation R2K	7.87	17.49	$99.29M	2.54%	27.27%	17.08%	3.46%	46.48%
2	WMT Walmart Inc. SPX	115.75	40.76	$922.64B	0.86%	18.21%	24.13%	5.27%	23.30%
3	COST Costco Wholesale Corporation NDXSPX	956.32	49.76	$424.27B	0.61%	27.44%	29.65%	6.64%	11.49%
4	KO The Coca-Cola Company SPX	79.01	24.85	$339.94B	2.68%	21.13%	43.37%	3.69%	11.16%
5	PG The Procter & Gamble Company SPX	143.56	21.02	$334.29B	2.97%	23.63%	31.11%	1.67%	2.71%
6	PM Philip Morris International Inc. SPX	177.38	24.98	$276.46B	3.31%	35.35%	-	8.57%	7.84%
7	PEP PepsiCo, Inc. NDXSPX	144.19	22.64	$197.10B	4.11%	15.23%	43.88%	2.83%	-2.57%
8	MO Altria Group, Inc. SPX	69.58	14.53	$116.19B	6.09%	40.85%	-	-0.89%	6.42%
9	MNST Monster Beverage Corporation NDXSPX	88.08	42.55	$86.14B	-	28.33%	26.65%	9.54%	16.94%

Quarterly Results

Figures in USD.

Metric	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Sep 2023	Dec 2023	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	49.13M	49.48M	50.56M	54.03M	55.61M	58.17M	56.01M	56.17M	56.23M	61.24M	56.08M	59.37M	54.83M	59.01M	51.57M	54.78M	53.22M	52.19M	50.00M	50.94M	51.77M	53.66M	53.74M	51.36M	51.62M	48.24M	-	-	58.44M	55.11M	47.56M	48.93M	43.72M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11.11M	11.06M	9.74M	12.72M	9.17M
Gross Profit	44.15M	46.45M	43.63M	46.06M	41.45M	36.77M	41.75M	40.39M	40.37M	41.64M	45.96M	46.41M	48.37M	46.74M	46.46M	47.04M	51.01M	46.98M	49.92M	45.43M	48.82M	42.75M	44.99M	43.79M	42.51M	40.35M	41.61M	41.83M	41.90M	43.12M	41.18M	40.56M	38.07M	-	-	47.33M	44.05M	37.82M	36.21M	34.54M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43.27M	41.90M	35.55M	35.72M	32.87M
Operating Income	3.03M	3.63M	-	1.99M	700.00K	223.00K	-	1.40M	2.33M	2.30M	-	1.32M	581.00K	2.24M	-	2.58M	3.65M	3.03M	-	3.50M	5.45M	2.09M	-	4.61M	-358.00K	1.82M	-	1.29M	-1.23M	1.60M	749.00K	-1.26M	1.93M	-	-	4.05M	2.15M	2.27M	487.00K	1.68M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.86M	2.90M	2.88M	1.24M	2.39M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.18M	2.40M	2.24M	473.00K	1.66M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	710.00K	437.00K	86.00K	197.00K	294.00K
Net Income	1.60M	1.00M	2.44M	1.18M	283.00K	61.00K	84.00K	817.00K	317.00K	1.64M	2.99M	911.00K	829.00K	1.78M	3.91M	1.76M	4.30M	1.66M	3.82M	2.45M	3.81M	1.72M	4.91M	3.32M	79.00K	1.14M	-1.42M	610.00K	-1.06M	1.02M	629.00K	-656.00K	1.66M	-	-	3.47M	1.96M	2.15M	276.00K	1.36M
Diluted EPS	0.11	0.07	0.17	0.08	0.02	0.00	0.01	0.06	0.02	0.12	0.21	0.06	0.06	0.12	0.26	0.12	0.30	0.11	0.26	0.17	0.26	0.12	0.35	0.25	0.01	0.09	-0.11	0.05	-0.08	0.08	0.05	-0.05	0.13	-	-	0.26	0.15	0.17	0.02	0.11
R&D Expense	-	-	-	300.00K	300.00K	200.00K	-	300.00K	300.00K	300.00K	-	400.00K	500.00K	100.00K	-	200.00K	300.00K	200.00K	-	200.00K	200.00K	200.00K	-	200.00K	200.00K	100.00K	-	100.00K	200.00K	200.00K	200.00K	100.00K	200.00K	300.00K	200.00K	400.00K	-	300.00K	200.00K	200.00K

Profit & Loss (Annual)

Figures in USD.

Metric	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Revenue	-	-	-	-	-	-	199.49M	203.20M	225.96M	232.91M	-	206.36M	213.40M	200.16M	228.53M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	38.10M	43.39M	41.44M	44.86M
Gross Profit	33.00M	108.13M	171.53M	180.77M	162.33M	172.61M	166.03M	168.36M	187.99M	194.95M	-	168.26M	170.01M	158.72M	183.67M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	160.69M	165.75M	154.39M	171.47M
Operating Income	3.70M	21.46M	12.07M	19.45M	13.90M	13.41M	4.45M	10.32M	9.81M	15.47M	-	7.58M	4.26M	4.33M	12.20M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	7.96M	7.84M	7.91M	15.36M
Interest Expense	-	-	-	-	-	-	-	-	-	-	17.00K	10.00K	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	4.69M	4.00M	4.35M	12.24M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	1.57M	1.46M	1.41M	2.44M
Net Income	-50.79M	12.47M	7.61M	11.38M	7.12M	6.11M	1.61M	5.76M	7.43M	11.55M	-	3.12M	2.54M	2.94M	9.80M
Diluted EPS	-0.69	0.11	0.06	0.71	0.50	0.42	0.11	0.41	0.50	0.79	0.90	0.24	0.20	0.23	-
R&D Expense	509.00K	1.40M	2.90M	2.00M	2.40M	1.00M	1.10M	1.20M	1.10M	900.00K	700.00K	700.00K	600.00K	700.00K	1.40M

Compounded Sales Growth

5 Years:	3.46%
1 Year:	-25.20%

Compounded Profit Growth

5 Years:	46.48%
1 Year:	-58.50%

Stock Price Performance

1 Year:	-38.47%
6 Months:	+18.16%
3 Months:	+70.90%
1 Month:	+55.84%

Balance Sheet (Annual)

Figures in USD.

Metric	Jun 2010	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jul 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Assets	-	12.50M	44.53M	55.48M	54.00M	39.78M	50.85M	45.25M	51.14M	-	55.27M	58.88M	-	70.71M	66.12M	60.30M	71.96M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	46.96M	44.28M	37.65M	50.89M
Cash & Equivalents	1.64M	6.37M	24.65M	26.30M	20.39M	13.90M	7.88M	11.46M	16.65M	-	18.82M	22.14M	-	20.19M	21.61M	16.89M	20.20M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	16.47M	16.07M	15.05M	20.67M
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	3.34M	1.61M	2.95M	3.29M
Total Liabilities	-	33.31M	16.25M	21.54M	50.01M	36.46M	40.21M	30.72M	29.20M	-	28.07M	25.62M	-	39.19M	31.47M	34.31M	37.32M
Current Liabilities	-	13.38M	16.03M	20.57M	22.70M	25.86M	30.63M	23.36M	23.80M	-	26.20M	25.02M	-	25.73M	19.61M	22.31M	27.22M
Long Term Debt	-	-	-	0	25.07M	8.53M	7.41M	5.44M	3.41M	-	0	-	-	-	-	-	-
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	15.76M	13.09M	13.61M	11.68M
Total Equity	-16.18M	-20.81M	28.28M	33.95M	2.33M	1.81M	10.65M	14.53M	21.95M	21.94M	27.20M	33.25M	-	31.52M	34.65M	25.99M	34.64M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	12.49M	12.62M	12.51M	12.43M

Cash Flows (Annual)

Figures in USD.

Metric	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Operating Cash Flow	4.68M	19.39M	10.66M	12.11M	13.22M	6.04M	6.60M	13.26M	17.79M	18.33M	-	7.96M	6.83M	12.20M	11.88M
Investing Cash Flow	-89.00K	-1.90M	-5.08M	-2.25M	-1.16M	-562.00K	-1.05M	-4.65M	-4.51M	-2.68M	-	-1.53M	-3.06M	-2.25M	-1.37M
Financing Cash Flow	169.00K	746.00K	-4.02M	-15.80M	-18.45M	-11.70M	-1.96M	-3.50M	-11.12M	-12.42M	-	-8.95M	-2.36M	-14.42M	-7.60M
Capital Expenditure	-122.00K	-2.19M	-5.08M	-1.90M	-1.16M	-562.00K	-1.05M	-4.65M	-2.51M	-2.68M	-	-1.53M	-3.07M	-2.25M	-1.37M
Free Cash Flow	4.56M	17.20M	5.58M	10.21M	12.06M	5.47M	5.54M	8.61M	15.28M	15.64M	-	6.43M	3.76M	9.95M	10.51M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-2.52M	1.41M	-4.46M	2.91M
Share Buybacks	0	976.00K	7.12M	46.17M	9.85M	0	0	1.50M	4.66M	5.41M	11.93M	8.83M	822.00K	6.43M	3.15M
Dividends Paid	-	-	-	-	-	-	-	-	-	0	0	378.00K	1.59M	6.94M	2.07M

Ratios (Annual)

Figures in %.

Metric	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Gross Margin %	-	-	-	-	-	-	83.2%	82.9%	83.2%	83.7%	-	81.5%	79.7%	79.3%	80.4%
Operating Margin %	-	-	-	-	-	-	2.2%	5.1%	4.3%	6.6%	-	3.7%	2.0%	2.2%	5.3%
Net Margin %	-	-	-	-	-	-	0.8%	2.8%	3.3%	5.0%	-	1.5%	1.2%	1.5%	4.3%
ROE %	244.1%	44.1%	22.4%	487.9%	394.5%	57.3%	11.1%	26.2%	27.3%	34.7%	-	9.9%	7.3%	11.3%	28.3%
ROCE %	-419.8%	75.3%	34.6%	62.1%	99.8%	66.3%	20.3%	37.8%	33.8%	45.7%	-	16.8%	9.2%	11.4%	27.3%

Shareholding Pattern

Insiders

16.43%

Institutions

67.28%

Public Float

80.51%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Capital Management Corporation	19.36%	2.44M	$19.22M
2	Renaissance Technologies, LLC	6.88%	867.70K	$6.83M
3	Blackrock Inc.	6.10%	769.70K	$6.06M
4	Vanguard Capital Management LLC	3.40%	429.42K	$3.38M
5	Dimensional Fund Advisors LP	2.19%	276.20K	$2.17M
6	Geode Capital Management, LLC	2.07%	261.19K	$2.06M
7	Envestnet Asset Management Inc.	1.74%	219.16K	$1.72M
8	Goldman Sachs Group Inc	1.47%	185.11K	$1.46M
9	State Street Corporation	1.32%	167.14K	$1.32M
10	AQR Capital Management, LLC	1.24%	156.10K	$1.23M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for LFVN

No recent headlines available.

LFVN · Consumer Defensive